InsiderClue
Insiders · Profile

Harper Sean E

EVP, Research & Development at Amgen. Filing since 27 Jul 2012. CIK 0001541946

Company
Date
Role
Action
Shares
Amount
Of holding
AMGN Amgen
16 Jul 2018
EVP, Research & Development
Sold, plan not stated
1,525
$298.46K
2.6%
AMGN Amgen
12 Jun 2018
EVP, Research & Development
Sold, plan not stated
1,525
$281.01K
2.6%
AMGN Amgen
14 May 2018
EVP, Research & Development
Sold, plan not stated
1,525
$265.50K
2.5%
AMGN Amgen
12 Apr 2018
EVP, Research & Development
Sold, plan not stated
1,525
$263.34K
2.6%
AMGN Amgen
16 Mar 2018
EVP, Research & Development
Sold, plan not stated
1,525
$289.37K
2.3%
AMGN Amgen
14 Feb 2018
EVP, Research & Development
Sold, plan not stated
1,525
$265.62K
2.8%
AMGN Amgen
16 Jan 2018
EVP, Research & Development
Sold, plan not stated
1,525
$283.07K
2.7%
AMGN Amgen
12 Dec 2017
EVP, Research & Development
Sold, plan not stated
1,525
$269.67K
2.6%
AMGN Amgen
13 Nov 2017
EVP, Research & Development
Sold, plan not stated
1,525
$261.66K
2.6%
AMGN Amgen
9 Oct 2017
EVP, Research & Development
Sold, plan not stated
1,525
$283.57K
2.5%
AMGN Amgen
29 Apr 2016
EVP, Research & Development
Sold, plan not stated
21,875
$3.46M
34.1%
AMGN Amgen
22 Apr 2015
EVP, Research & Development
Sold, plan not stated
28,000
$4.80M
36.9%
AMGN Amgen
5 Aug 2014
EVP, Research & Development
Sold, plan not stated
14,000
$1.78M
19.0%
AMGN Amgen
2 May 2013
EVP, Research & Development
Sold, plan not stated
8,000
$850.59K
11.1%
AMGN Amgen
27 Jul 2012
EVP, Research & Development
Sold, plan not stated
39,900
$3.29M
43.2%
15 decisions on file.